Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000162452 | SCV000212805 | likely benign | Hereditary cancer-predisposing syndrome | 2014-08-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000206094 | SCV000261005 | likely benign | Li-Fraumeni syndrome | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000410097 | SCV000487941 | likely benign | Li-Fraumeni syndrome 1 | 2015-12-04 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000162452 | SCV000537510 | likely benign | Hereditary cancer-predisposing syndrome | 2015-12-14 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000989696 | SCV001140235 | likely benign | Squamous cell carcinoma of the head and neck | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001711320 | SCV001940215 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001711320 | SCV002047298 | likely benign | not provided | 2021-01-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000162452 | SCV002582198 | likely benign | Hereditary cancer-predisposing syndrome | 2022-06-18 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000410097 | SCV002582761 | likely benign | Li-Fraumeni syndrome 1 | 2022-06-18 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000410097 | SCV004017851 | benign | Li-Fraumeni syndrome 1 | 2023-04-11 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Ce |
RCV001711320 | SCV004184643 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | TP53: BP4, BP7 |
All of Us Research Program, |
RCV000206094 | SCV004823713 | likely benign | Li-Fraumeni syndrome | 2023-12-18 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001354955 | SCV001549689 | uncertain significance | Carcinoma of colon | no assertion criteria provided | clinical testing | The TP53 p.Leu383= variant was not identified in the literature nor was it identified in the LOVD 3.0 or UMD-LSDB databases. The variant was also identified in dbSNP (ID: rs373710656) as "With Likely benign allele" and ClinVar (classified as likely benign by Invitae, Counsyl, Ambry Genetics and Color). The variant was identified in control databases in 9 of 246266 chromosomes at a frequency of 0.00004 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: European in 8 of 111716 chromosomes (freq: 0.00007) and Latino in 1 of 33582 chromosomes (freq: 0.00003), while it was not observed in the African, Ashkenazi Jewish, East Asian, Finnish, Other, or South Asian populations. The p.Leu383= variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. However, 1 of 4 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) predict a greater than 10% difference in splicing; this is not very predictive of pathogenicity. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. |